Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,000
Closed -$160K 4364
2016
Q4
$160K Sell
1,000
-1,400
-58% -$206K ﹤0.01% 3526
2016
Q3
$339K Buy
+2,400
New +$334K ﹤0.01% 2688
2015
Q3
Sell
-9,300
Closed -$1.22M 5148
2015
Q2
$1.22M Sell
9,300
-10,900
-54% -$1.35M 0.01% 1903
2015
Q1
$2.41M Buy
20,200
+12,200
+153% +$1.35M 0.02% 1124
2014
Q4
$845K Buy
8,000
+3,000
+60% +$317K 0.01% 2095
2014
Q3
$515K Buy
5,000
+4,000
+400% +$405K ﹤0.01% 2456
2014
Q2
$94K Sell
1,000
-10,600
-91% -$940K ﹤0.01% 3755
2014
Q1
$1.04M Buy
11,600
+8,600
+287% +$701K 0.01% 1834
2013
Q4
$230K Sell
3,000
-50,000
-94% -$3.69M ﹤0.01% 3410
2013
Q3
$1.9M Buy
53,000
+41,200
+349% +$2.93M 0.01% 1581
2013
Q2
$855 Buy
+11,800
New +$865K ﹤0.01% 2277

Other funds holding CHE

PEAK6 Group's CHE Position: Q4 2017 in Review

PEAK6 Group sold out of Chemed (CHE) in Q4 2017, closing a stake of 3,011 shares — an estimated $608K sold.

PEAK6 Group first reported a position in CHE in Q2 2013 and held it in 6 quarters. The position peaked at $608K in Q3 2017. 299 funds tracked by Wall St. Rank hold CHE as of Q4 2017.

  • PEAK6 Group reported no remaining Chemed position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 3,011 Chemed shares in Q4 2017, an estimated $608K.
  • PEAK6 Group first reported a position in Chemed in Q2 2013 and held it in 6 quarters.
  • PEAK6 Group's Chemed position peaked at $608K in Q3 2017.
  • 299 funds tracked by Wall St. Rank held Chemed as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.